SEC Form 4 · accession 0001645627-17-000044
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Apr 25, 2017
Accepted (ET)
Apr 27, 2017 · 12:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.068 | A | 20,336,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.068 | A | 20,337,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.068 | A | 20,338,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.068 | A | 20,339,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.071 | A | 20,340,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.071 | A | 20,341,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0714 | A | 20,342,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0714 | A | 20,343,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.072 | A | 20,344,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0739 | A | 20,345,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0739 | A | 20,346,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.074 | A | 20,347,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.074 | A | 20,348,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.074 | A | 20,349,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,350,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.07 | A | 20,351,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,352,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.072 | A | 20,353,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,354,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,355,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,356,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0729 | A | 20,357,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,358,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,359,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,360,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,361,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,362,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.073 | A | 20,363,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0727 | A | 20,364,949 | D | |
| Common Stock | Apr 25, 2017 | P | 1,000 | $0.0701 | A | 20,365,949 | D |
Table II — derivative securities
No Table II lines on this filing.